MARCY SMITH: Open Payments
NPI 1629093067 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 14 payments from 7 companies in 2025. Trend: 2023 $603 · 2024 $796 · 2025 $469
Food & beverage: $448Education: $20
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $196 |
| E.R. Squibb & Sons, L.L.C. | 3 | $146 |
| Novo Nordisk Inc | 2 | $39 |
| Amgen Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Biosense Webster, Inc. | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $12 |
Products named: Kerendia, CAMZYOS, Ozempic, REPATHA, LEQVIO, CARTO 3, ELIQUIS, LifeVest.
Industry payments across TX — which companies pay providers there.
